Robert Patitucci
Family Medicine · Bridgeton, NJNPI 1902807480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 371 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Novo Nordisk at 24.3% of the total.
Across 371 payments — averaging $12.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$524
- AbbVie$519
- AstraZeneca$378
- Amgen$224
- Novartis$169
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,435100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 115 | $1,085 |
| GSK | 47 | $524 |
| AbbVie(2 entities) | 41 | $519 |
| AstraZeneca | 29 | $378 |
| Amgen | 18 | $224 |
| Novartis | 12 | $169 |
| Merck | 12 | $153 |
| Esperion Therapeutics, Inc. | 10 | $136 |
| Pfizer | 10 | $129 |
| Bayer | 5 | $104 |
| Philips North America LLC | 6 | $93 |
| Indivior Inc. | 7 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $80 |
| Boehringer Ingelheim | 6 | $79 |
| Sanofi-aventis U.S. LLC | 5 | $77 |
| Amarin Pharma, Inc. | 5 | $73 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Alkermes, Inc. | 4 | $56 |
| Lilly USA, LLC | 4 | $56 |
| Dexcom, Inc. | 3 | $51 |
| Endo Pharmaceuticals Inc. | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $41 |
| Lundbeck LLC | 2 | $29 |
| Nalpropion Pharmaceuticals LLC | 2 | $28 |
| Eisai Inc. | 2 | $27 |
| Gilead | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Abbott | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$4,456 in reported general payments places this provider in the 85th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Bridgeton
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
- Sally MravcakJersey City$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.